A.A. Ibrahim, P.-H. Wei, G.D. Harzmann et al.
Tetrahedron 78 (2021) 131838
aqueous H2O2 solution (50%, 2 drops) at room temperature. After
stirring for 10 min at room temperature, the solvent was removed
under reduced pressure. The crude product was dissolved in 10%
EtOAc/hexane (5 mL) and dichloromethane (1 mL). The resulting
solution was passed through a plug column of neutral silica
(iatrobeads, 2 ꢃ 2 cm, 4 g) [50 x weight of reaction mixture]. The
plug column was eluted with 10% EtOAc/hexane (100 mL), and the
solvent was removed under vacuum to furnish the desired keto-
ketene dimer with ꢀ95% purity in most cases (as determined by
GC-MS and 1H NMR analysis). Further purification was carried out
in some cases as specified.
4.3.1.7. Z-3-Ethyl-3-phenyl-4-(1-phenyl-propylidene)-oxetan-2-one
(( )-2b). Method A was followed. Ethylphenylketene 1b (160 mg,
1.09 mmol), stirred for 4 h at 0 ꢂC, was isolated as a colorless oil
(135 mg, 84%); IR (thin film): 1857, 1699, 1140 cmꢁ1 1H NMR
;
(200 MHz, CDCl3, TMS):
d 7.42e7.20 (m, 10H), 2.38e2.02 (m, 4H),
1.15 (t, J ¼ 7.4 Hz, 3H), 0.83 (t, J ¼ 7.4 Hz, 3H); 13C NMR (50 MHz,
CDCl3):
d 170.9, 143.9, 135.4, 134.7, 129.3, 128.6, 128.6, 128.2, 127.6,
126.5, 116.5, 70.1, 26.3, 22.9, 12.8, 10.0; MS (EI 70 eV): m/z 292, 146,
117, 103, 91, 77; (M þ Na)þ HRMS m/z calcd for C20H20O2Na:
315.1355; found: 315.1351.
4.3.1.8. Z-3-Butyl-3-phenyl-4-(1-phenylpentylidene)-oxetan-2-one
(( )-2c). Method B was followed. n-Butylphenylketene 1c (108 mg,
0.62 mmol), stirred for 1.5 h at 0 ꢂC, was isolated as a colorless oil
4.3.1.4. Method D for asymmetric homodimerization of ketoketenes.
Ketoketene (0.31 mmol, 1.0 equiv) was dissolved in CH2Cl2 (1 mL)
and cooled to ꢁ25 ꢂC. (R)-1-[(Sp)-2-(Diphenylphosphino)ferro-
cenyl]ethyldicyclohexylphosphine or (S)-1-[(Rp)-2-(Diphenyl-
phosphino)ferrocenyl]ethyldicyclohexylphosphine (0.03 mmol, 0.1
equiv) was dissolved in CH2Cl2 (0.35 mL), cooled to ꢁ25 ꢂC in most
cases (exceptions: formation of 2l and 4o), and was then trans-
ferred via syringe to the flask containing the ketoketene solution.
The resulting solution (0.25 M of ketoketene in solvent) was stirred
for 24 h at ꢁ25 ꢂC before being briefly warmed to room tempera-
ture. The reaction was then quenched by the addition of aqueous
H2O2 solution (50%, 2 drops) at room temperature. After stirring for
10 min at room temperature, the solvent was removed under
reduced pressure. The crude product was dissolved in 10% EtOAc/
hexane (5 mL) and dichloromethane (1 mL). The resulting solution
was passed through a plug column of neutral silica (iatrobeads,
2 ꢃ 2 cm, 4 g) [50 x weight of reaction mixture]. The plug column
was eluted with 10% EtOAc/hexane solvent system (100 mL), and
the solvent was removed under vacuum to furnish the desired
ketoketene dimer with ꢀ95% purity in most cases (as determined
by GC-MS and 1H NMR analysis). Further purification was carried
out in some cases as specified.
(108 mg, >99%); IR
(thin film): 1869, 1703 cmꢁ1 1H NMR
;
n
max
(400 MHz, CDCl3, TMS):
d 7.38e7.19 (m, 10H), 2.30e2.19 (m, 2H),
2.12e2.04 (m, 2H), 1.61e1.36 (m, 2H), 1.28e1.02 (m, 2H), 0.90 (t,
J ¼ 7.2 Hz, 3H), 0.86e0.74 (m, 4H), 0.69 (t, J ¼ 7.1 Hz, 3H); 13C NMR
(100 MHz, CDCl3):
d 171.1, 144.8, 135.6, 135.1, 129.3, 128.6, 128.5,
128.2, 127.6, 126.5, 115.3, 69.3, 32.9, 30.4, 29.5, 27.6, 23.0, 22.8, 14.1,
14.0; MS (EI 70 eV): m/z 348, 264, 205, 174, 131, 117, 103; (M þ Na)þ
HRMS m/z calcd for C24H28O2Na: 371.1982; found: 371.1984.
4.3.1.9. Z-3-Benzyl-4-(1,2-diphenylethylidene)-3-phenyloxetan-2-
one (( )-2e). Method B was followed. Benzylphenylketene 1e
(111 mg, 0.53 mmol), stirred for 5 h at room temperature. Crude 2e
was obtained with 64% conversion as determined by GC-MS anal-
ysis; MS (EI 70 eV): m/z 416, 281, 208, 179.
4.3.1.10. Z-3-(2-Chlorophenyl)-4-(1-(2-chlorophenyl)ethylidene)-3-
methyloxetan-2-one (( )-2g). Method
chlorophenylketene 1g (60 mg, 0.36 mmol), stirred for 1.5 h at
ꢂC, was isolated as a colorless oil (60 mg, >99%); IR
(thin
B was used. Methyl-2-
0
n
max
film): 1891, 1843, 1725, 1647 cmꢁ1; 1H NMR (400 MHz, CDCl3, TMS):
7.48e7.12 (m, 8H), 2.06 (s, 3H), 1.68 (s, 3H); 13C NMR (100 MHz,
CDCl3): 169.8, 145.7, 136.0, 134.9, 133.4, 132.0, 131.5, 130.7, 130.3,
130.0, 129.3, 128.8, 127.5, 127.1, 108.5, 62.1, 20.0, 16.1; MS (EI 70 eV):
m/z 332, 166, 138, 103; (M
Na)þ HRMS m/z calcd for
18H14Cl2O2Na: 355.0263; found: 355.0266.
d
4.3.1.5. Method E for asymmetric homodimerization of ketoketenes.
Ketoketene (0.34 mmol, 1.0 equiv) was dissolved in CH2Cl2
(0.35 mL) and was cooled to ꢁ78 ꢂC. (R)-Binaphane (0.03 mmol, 0.1
equiv) was dissolved in CH2Cl2 (0.35 mL) and cooled to ꢁ78 ꢂC. The
phosphepine solution was then transferred via syringe to the flask
containing the ketoketene solution. The reaction was stirred
at ꢁ78 ꢂC for 48 h, after which the solvent was removed under
reduced pressure. The crude product was treated with dry iso-
propanol (3 mL) to dissolve the crude ketoketene dimer and pre-
cipitate the phosphepine. The mixture was filtered under nitrogen
using a Schlenk filter funnel. The precipitate was washed with dry
isopropanol (2 ꢃ 3 mL), the phosphine was recovered, and the
solvent was removed from the filtrate under reduced pressure. The
crude product was then dissolved in 5% EtOAc/hexane (6 mL) and
CH2Cl2 (1.5 mL), before being passed through a plug of neutral silica
(3.3 g). Elution with 5% EtOAc/hexane (60 mL), followed by solvent
removal under reduced pressure furnished the desired ketoketene
dimer with ꢀ95% purity in most cases (as determined by GC-MS
and 1H NMR analysis). Further purification was carried out in
some cases as specified.
d
þ
C
4.3.1.11. Z-3-Methyl-3-o-tolyl-4-(1-o-tolylethylidene)oxetan-2one
(( )-2h). Method B was used. Methyl-2-tolylketene 1h (50 mg,
0.34 mmol), stirred for 1 h at 0 ꢂC, was isolated as a colorless oil
(49 mg, 97%); IR n max (thin film): 1883, 1844, 1717, 1456, 1112 cmꢁ1
;
1H NMR (400 MHz, CDCl3, TMS):
2.15 (s, 3H), 2.10 (s, 3H), 1.79 (s, 3H); 13C NMR (100 MHz, CDCl3):
171.2, 145.3, 137.7, 136.8, 136.0, 133.1, 132.7, 130.6, 128.7, 128.5,
d 7.43e7.10 (m, 8H), 2.26 (s, 3H),
d
128.0, 127.1, 126.6, 126.1, 110.3, 63.3, 20.6, 20.5, 19.9, 17.5; MS (EI
70 eV): m/z 292, 264, 249, 146, 117, 91; (M þ Na)þ HRMS m/z calcd
for C20H20O2Na: 315.1356; found: 315.1359.
4.3.1.12. Z-3-Ethyl-3-thiophen-3-yl-4-(1-thiophen-3-yl-propyli-
dene)-oxetan-2-one (( )-2l). Method
thiophenylketene 1l (162 mg, 1.06 mmol), stirred for 7 h at 0 ꢂC,
isolated as a colorless oil (127 mg, 78%); IR (thin film): 1859,
A
was used. Ethyl-3-
n
max
1695, 1411 cmꢁ1 1H NMR (200 MHz, CDCl3, TMS):
; d 7.30e7.16 (m,
4.3.1.6. Z-3-Methyl-3-phenyl-4-(1-phenyl-ethylidene)-oxetan-2-one
(( )-2a). Method A was followed. Methylphenylketene 1a (270 mg,
2.05 mmol), stirred for 2 h at 0 ꢂC, and was isolated as a colorless oil
(221 mg, 82%); IR (thin film) 1881, 1844, 1699, 1140 cmꢁ1; 1H NMR
4H), 7.05e7.02 (m, 2H), 2.39e2.01 (m, 4H), 1.09 (t, J ¼ 7.3 Hz, 3H),
0.92 (m, J ¼ 7.4 Hz, 3H); 13C NMR (50 MHz, CDCl3):
d 170.1, 144.5,
136.1, 135.4, 127.4, 127.1, 126.1, 125.5, 122.6, 122.4, 111.3, 67.5, 26.1,
22.6,13.5, 9.7; MS (EI 70 eV): m/z 247,152,123, 97; (M þ Na)þ HRMS
m/z calcd for C16H16O2S2Naþ: 327.0484; found: 327.0485.
(200 MHz, CDCl3, TMS):
d
7.52e7.16 (m, 10H), 1.92 (s, 3H), 1.86 (s,
171.4, 146.9, 136.2, 135.2, 129.4,
3H); 13C NMR (50 MHz, CDCl3):
d
128.6, 128.6, 127.6, 127.4, 126.3, 108.6, 64.4, 19.6, 15.6; MS (EI 70 eV):
m/z 264, 132, 104, 78; (M þ Na)þ HRMS m/z calcd for C18H16O2Na:
287.1043; found: 287.1039.
4.3.1.13. 2,4-Dicyclohexyl-2,4-diethylcyclobutane-1,3-dione
(4o).
Method A was used. Ethyl c-hexyl ketene 1o (52 mg, 0.34 mmol),
stirred at 0 ꢂC to room temperature overnight. Crude 4o was
9